Proteins and peptides now constitute a major proportion of therapeutic modalities being pursued for the treatment of various diseases 1. Nearly 30% of all drugs approved by the US Food and Drug ...
U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa - First ...
Gilead Receives Complete Response Letter from U.S. Food and Drug Administration for Aztreonam Lysine for Inhalation, an Investigational Treatment for Cystic Fibrosis FOSTER CITY, Calif. -- Sept. 16, ...
In a first-of-its kind study, young children undergoing heart surgery had similar results regardless of whether they received levosimendan intravenously or via inhalation. Pediatric patients who ...
Amneal Pharmaceuticals (AMRX) announced that the U.S. Food and Drug Administration, FDA, has approved the Company’s albuterol sulfate inhalation ...
PITTSBURGH and ST. PAUL, Minn., March 8, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted ...
The FDA has granted Orphan Drug Designation to Tacrolimus Inhalation Powder (TFF Pharmaceuticals) for prophylaxis of lung allograft rejection. The Food and Drug Administration (FDA) has granted Orphan ...
SHENZHEN, China, April 10, 2024 /PRNewswire/ -- Recently, Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback